1.A Case of Ocular Myasthenia Gravis with Thytmolipoma and Thymic Cyst.
Jin Kuk KIM ; Hyeon Suk BYEON ; Jae Cheol KWEON ; Te Gyu LEE ; Choong Kun HA ; Byeong Hoon LIM
Journal of the Korean Neurological Association 1995;13(3):676-681
The incidence of thymolipoma or thynuc cyst is very rare among the tumors of thymic origin, which are usually benign or invasive thymoma. Thymic tumor has been found among 10 to 15% of the patients with myasthenia gravis(MG). However the patients with thymolipoma or thynuc cyst rarely manifestated as MG. Moreover the case of MG with thymolipoma and thymic cyst is extremely rare ; Only one case has been reported hitherto. We hereby report a 41-year-old woman presenting as ocular MG with thymolipoma and thymic cyst. She complained diplopia, ptosis and headache, which had begun 3 months prior to admission and have been fluctuating thereafter. Ocular MG was confirmed by positive Tensilon and Jolly test. Her chest CT showed an enlarged thymus which turned out to be thymolipoma with thymic cyst on the pathologic examination. Although rare, thymolipoma and/or thymic cyst should be considered in the differential diagnosis of thymic tumor in MG.
Adult
;
Diagnosis, Differential
;
Diplopia
;
Edrophonium
;
Female
;
Headache
;
Humans
;
Incidence
;
Mediastinal Cyst*
;
Myasthenia Gravis*
;
Thymoma
;
Thymus Gland
;
Thymus Neoplasms
;
Tomography, X-Ray Computed
2.Effect of Percutaneous Aspiration and Repeated Sclerotherapy of the Simple Renal Cyst.
Sung Gi MIN ; Myung Seop BOO ; Jae Il JUNG ; Ho Cheol CHOI ; Kweon Sik MIN ; Sung Hyup CHOI ; Sang Suk HAN
Korean Journal of Urology 1996;37(9):986-989
Recently the percutaneous aspiration and sclerotherapy has become the most advocated procedure for the symptomatic, large, and simple renal cyst because of its minimal invasiveness and high effectiveness. But the recurrence rate of the simple aspiration and sclerotherapy was reported highly (30-70%). We analysed the effect of percutaneous aspiration and repeated sclerotherapy of the renal cyst in 42 patients from Nov. 1989 to Apr. 1995. Sclerosing agent were 99% ethanol in 33 cases, minocycline in 4 cases, and only aspiration was done in 6 cases. The method of repeated sclerotherapy was achieved about 2.2 times as which aspiration and instillation of sclerosing agent in standing of 8.3 Fr. pigtail catheter during average 2.5 days. After follow up for 17.4 (6-59) months, the complete collapse rate of the renal cyst was 78.7% in the using group of 99% ethanol. 25% in minocycline, 16.696 in the aspiration only. The complete collapse rate according to the times of sclerotherapy was 45.5% in one times, 78.6% in two times, 92% in three times. In conclusion, the sclerotherapy of the simple renal cyst with 99% ethanol was most effective, and we can be expect that the rate of complete collapse has been increased in the repeated sclerotherapy.
Catheters
;
Ethanol
;
Follow-Up Studies
;
Humans
;
Minocycline
;
Recurrence
;
Sclerotherapy*
3.A Case of Primary Antiphospholipid Syndrome associated with Chronic Hepatitis C.
Min Ki KIM ; Eun Taek PARK ; Yeun Sik JANG ; Jin Ho SONG ; Youn Jae LEE ; Sang Hyuk LEE ; Sang Young SEOL ; Jung Myung CHUNG ; Do Cheol KWEON
Korean Journal of Medicine 1998;54(6):856-860
Hepatitis C was known to be associated with many autoimmune disease, but the pathophysiology was not well understood. Antiphospholipid antibodies, which are autoantibodies detected to negatively charged phospholipids, are sometimes detected in infectious diseases, including sypilis and autoimmun diseases, such as systemic lupus erythematosus and unknown etiology. A few reports suggested that there is a relation between primary antiphospholipid syndrome and hepatitis C. We recently experienced a case of primary antiphospholipid syndrome with chronic hepatitis C in 20 years old womam who developed cerebral infartion. A brief review of related literature is presented.
Antibodies, Antiphospholipid
;
Antiphospholipid Syndrome*
;
Autoantibodies
;
Autoimmune Diseases
;
Communicable Diseases
;
Hepatitis C
;
Hepatitis C, Chronic*
;
Hepatitis, Chronic*
;
Humans
;
Lupus Erythematosus, Systemic
;
Phospholipids
;
Young Adult
4.Treatment preferences in men with erectile dysfunction: an open label study in Korean men switching from sildenafil citrate to tadalafil.
Tai Young AHN ; Sung Won LEE ; Sae-Woong KIM ; Dae Yul YANG ; Nam Cheol PARK ; Kweon-Sik MIN ; Kwangsung PARK ; Jae-Seung PAICK ; Yulia DYACHKOVA ; Trisha DWIGHT ; Myung-Sea Luke LEE
Asian Journal of Andrology 2007;9(6):760-770
AIMTo evaluate patient preferences for sildenafil citrate or tadalafil (PDE-5 inhibitors available for the treatment of erectile dysfunction [ED]) and assess potential reasons for these preferences.
METHODSThis open-label study was conducted on Korean men taking sildenafil, at least 6 weeks prior to study entry, for ED. Following screening, patients continued sildenafil treatment for 4 weeks, then after a 1-week washout period, switched to tadalafil for 8 weeks. Patients then continued with their treatment of choice during an extension phase. Psychosocial factors (time concern, spontaneity, sexual self-confidence) were evaluated using Psychological and Interpersonal Relationship Scales (PAIRS), while timing of dose to sexual attempt patterns were assessed from patient diaries.
RESULTSThe present study enrolled 160 Korean men (mean age 55 years) with prior median sildenafil use of 585 days. During the extension phase, 73.7% of patients elected to take tadalafil, whereas 26.3% chose sildenafil (P < 0.001). After switching from sildenafil to tadalafil, mean PAIRS time concern scores decreased from 2.54 to 2.42 (P = 0.002), with no statistically significant differences observed between the sildenafil and tadalafil assessment phases in sexual spontaneity and self-confidence scores. Sexual attempts made > 4 h to =/< 36 h post-dose occurred in 4.5% of patients during the sildenafil assessment phase compared with 17.5% during the tadalafil assessment phase.
CONCLUSIONAfter experiencing both sildenafil and tadalafil, the majority of patients exhibited a preference for tadalafil. This preference might be influenced by psychosocial factors, such as decreased time concerns, and a broader window of opportunity available for sexual activity.
Adult ; Aged ; Carbolines ; therapeutic use ; Dose-Response Relationship, Drug ; Erectile Dysfunction ; drug therapy ; ethnology ; psychology ; Humans ; Korea ; Male ; Middle Aged ; Patient Satisfaction ; statistics & numerical data ; Phosphodiesterase Inhibitors ; therapeutic use ; Piperazines ; therapeutic use ; Psychology ; Purines ; therapeutic use ; Sildenafil Citrate ; Sulfones ; therapeutic use ; Tadalafil ; Treatment Outcome
5.(-)-Epigallocatechin Gallate Inhibits the Pacemaker Activity of Interstitial Cells of Cajal of Mouse Small Intestine.
Kweon Young KIM ; Soo Jin CHOI ; Hyuk Jin JANG ; Dong Chuan ZUO ; Pawan Kumar SHAHI ; Shankar Prasad PARAJULI ; Cheol Ho YEUM ; Pyung Jin YOON ; Seok CHOI ; Jae Yeoul JUN
The Korean Journal of Physiology and Pharmacology 2008;12(3):111-115
The effects of (-)-epigallocatechin gallate (EGCG) on pacemaker activities of cultured interstitial cells of Cajal (ICC) from murine small intestine were investigated using whole-cell patch-clamp technique at 30degrees C and Ca2+ image analysis. ICC generated spontaneous pacemaker currents at a holding potential of -70 mV. The treatment of ICC with EGCG resulted in a dose-dependent decrease in the frequency and amplitude of pacemaker currents. SQ-22536, an adenylate cyclase inhibitor, and ODQ, a guanylate cyclase inhibitor, did not inhibit the effects of EGCG. EGCG-induced effects on pacemaker currents were not inhibited by glibenclamide, an ATP-sensitive K+ channel blocker and TEA, a Ca2+-activated K+ channel blocker. Also, we found that EGCG inhibited the spontaneous [Ca2+]i oscillations in cultured ICC. In conclusion, EGCG inhibited the pacemaker activity of ICC and reduced [Ca2+]i oscillations by cAMP-, cGMP-, ATP-sensitive K+channel-independent manner.
Adenine
;
Adenylyl Cyclases
;
Animals
;
Gastrointestinal Motility
;
Glyburide
;
Guanylate Cyclase
;
Interstitial Cells of Cajal
;
Intestine, Small
;
Mice
;
Patch-Clamp Techniques
;
Tea
6.A Case of Combined Hepatocellular-Cholangiocarcinoma with Sarcomatous Transformation and Second Primary Colon Cancer.
Jae Hi KIM ; Yong Gu LEE ; Jun LEE ; Cheol Kweon JUNG ; Hyeong Tae KIM ; Haeyoun KANG ; Kwang Hyun KHO ; Sung Pyo HONG ; Seong Gyu HWANG ; Pil Won PARK ; Gyu Sung RIM
The Korean Journal of Hepatology 2004;10(2):142-147
Combined hepatocellular-cholangiocarcinoma is a rare form of primary liver cancer, featuring both hepatocellular and biliary epithelial differentiations. An intrahepatic tumor may be considered as a metastatic lesion. It has been suggested in the literature that the likelihood of metastasis in the cirrhotic liver is lower than that in the non-cirrhotic liver. A rare case of combined hepatocellular-cholangiocarcinoma and second primary colon adenocarcinoma in a 67-year-old male patient with liver cirrhosis is presented. Histologically, the intrahepatic mass was composed of a spindle cell sarcomatous component; a hepatocellular carcinoma component; and a cholangiocarcinoma component. There were focal transitional regions among the different components. Immunohistochemically, the cholangiocarcinoma component of the intrahepatic mass showed positive reactions for CK-7 but negative reactions for CK-20. The adenocarcinoma of the colon showed positive reactions for CK-20 but negative reactions for CK-7.
Adenocarcinoma/*pathology
;
Aged
;
Bile Duct Neoplasms/*pathology
;
*Bile Ducts, Intrahepatic
;
Carcinoma, Hepatocellular/*pathology
;
Cholangiocarcinoma/*pathology
;
Colonic Neoplasms/*pathology
;
English Abstract
;
Humans
;
Liver Neoplasms/*pathology
;
Male
;
Neoplasms, Second Primary/*pathology
7.Comparative Study of Signal-Averaged Electrocardiogram between Time Domain Analysis and Spectral Turbulence Analysis by 24-hr Holter Monitoring.
Chang Won LEE ; Duk Whan JANG ; In Seok BAEK ; Jang Won KIM ; Soon Chul BAE ; Cheol Woo KIM ; Jae Koo KWEON ; Rak Kyeong CHOI ; Moo Yong RHEE ; Hong Soon LEE ; Soo Woong YOO
Korean Journal of Medicine 1997;52(4):500-507
OBJECTIVES: Signal-averaged electrocardiography (SAECG) has been found to be a useful noninvasive technique for identifying patients at risk for life-threatening ventricular tachycardia. Delayed and fragmented activation of abnormal myocardial tissues causes the occurrence of high frequency low amplitude (HFLA) electocardiographic signals or late potentials. Generally, there are two methods in analyzing signal-averaged electrocardiography. Late potentials in the time domain analysis do not provide sufficient diagnostic power with regard to life-threatening Ventricular tachycardia. Buckingham et al. (1989) reported a time-domain sensitivity of 62%, a specificity of 75%. Spectral turbulence analysis (STA) of the signal-averaged ECG is the most recent frequency domain technique to improve the time domain sensitivity and specificity. So, We designed the study to compare the efficacy of Time Domain Analysis and Spectral Turbulence Analysis among five groups (Normal control, QRS widening, Postmyocardial infarction, Frequent VPC's with group beats, Nonsustained ventricular tachycardia). METHODS: 88 patients were selected from the patients who had been admitted between January 1994 and October l994, at National Medical Center. Patients were divided into five groups, which were respectively, Group A: Normal control group (n=33), Group B: QRS widening group (n=14), Group C: Postmyocardial infarction group (n=10), Group D: Frequent VPC's with group beats (n=22), Group E: Nonsustained VT group (n=9). We compared Spectral Turbulence Analysis and Time Domain Analysis of Signal-Averaged Electrocardiogram by 24 hours-Holter monitoring. RESULTS: 1) In normal control group(Group A), 9.1%(3 patients) were positive by Time Domain Analysis, but, all were negative by Spectral Turbulence Analysis. 2) In QRS widening group (Group B), 71.4%(10 patients) were positive by Time Domain Analysis, but, all were negative by Spectral Turbulence Analysis. 3) In postmyocardial infarction group (Group C), 309o were positive by Time Domain Analysis, and 10% were positive by Spectral Turbulence Analysis. 4) In frequent VPC's group (Group D), 22.7% (5 patients) were positive by Time Domain Analysis, and, 4.5%(1 patient) was positive by Spectral Tur-bulence Analysis. 5) In Nonsustained VT group (Group E), 33.3% (3 patients) were positive by Time Domain Analysis, and 11.1% (1 patient) was positive by Spectral Turbulence Analysis. CONCLUSIONS: In Time Domain Analysis, abnormal results were presented at Group R (QRS widening group) by 71.4%, which was markedly higher than other groups. But, in Spectral Turbulence Analysis, abnormal results were not presented at Group A and Group B. In Group A and Group B, Spectral Turbulence Analysis shows less false positive results than Time Domain Analysis.
Electrocardiography*
;
Electrocardiography, Ambulatory*
;
Humans
;
Infarction
;
Sensitivity and Specificity
;
Tachycardia, Ventricular
8.A Case of Type I Duodenal Perforation Treated with Covered Metal Stent.
Jun LEE ; Kwang Hyun KO ; Jeong Ki KIM ; Cheol Kweon JEONG ; Sun Hye JUNG ; Jae Hyun MOON ; Sung Pyo HONG ; Seong Gyu HWANG ; Pil Won PARK ; Kyu Sung RIM
Korean Journal of Gastrointestinal Endoscopy 2005;30(2):95-98
Endoscopic retrograde cholangiopancreatography (ERCP) has played an important role in diagnosis and management of biliary disease. Traditionally, duodenal perforations, rare complication of ERCP, have been managed surgically. However, in the past decade, there were arguments for surgical and nonsurgical management of ERCP-related duodenal perforations and reports of successful conservative treatment were increasing especially in patients with old age and poor medical conditions. We experienced a case of type I duodenal perforation following ERCP treated with covered metal stent in 74 years old female with duodenal invasion by Klatskin tumor.
Aged
;
Cholangiopancreatography, Endoscopic Retrograde
;
Diagnosis
;
Female
;
Humans
;
Klatskin's Tumor
;
Stents*
9.Comparative Analysis of Clinical Parameters in Acute Pyelonephritis.
Yon Hwan JUNG ; In Rae CHO ; Seung Eon LEE ; Keon Cheol LEE ; Jong Gu KIM ; Joon Seong JEON ; Seok San PARK ; An Sik ROH ; Won Jae YANG ; Luck Hee SUNG ; Jae Yong JUNG ; Choong Hee NOH ; Jae Il CHUNG ; Kweon Sik MIN ; Dong Il KANG ; Seung Hyup CHOI ; Duk Yoon KIM ; Sang Don LEE ; Hong Sup KIM ; Dong Hyun LEE ; Do Hwan SEUNG ; Young Seop CHANG ; Ki Hak SONG ; Kyung Seop LEE ; Dong Soo PARK ; Young Ho KIM ; Min Eui KIM
Korean Journal of Urology 2007;48(1):29-34
PURPOSE: To compare the variable inflammatory parameters of acute pyelonephritis patients treated with inpatient therapy at 13 hospitals, according to the age and gender distributions. MATERIALS AND MATHODS: A total of 3,544 medical records of patients with confirmed acute pyelonephritis, and admitted to hospital between January 2000 and December 2005, were retrospectively analyzed. RESULTS: The mean age of the patients was 43.2+/-16.2 years old, with a male:female ratio of 1 : 5.1. The average duration of hospital admission was 7.9+/-5.3 days. Underlying diseases were found in 23.0% (749/3,252 patient), largely due to diabetes (35.1%). Radiological abnormal findings were found in 13.7%. The leukocyte count, ratio of segmented form, erythrocyte sedimentation rate (ESR), c-reactive protein, pyuria, positive blood culture, positive urine culture were 11,014+/-5,778/mm(3), 74.8+/-14.5%, 44.0+/-32.0 mm/hr, 12.4+/-9.3mg/dl, 83.9%, 10.5% and 46.7%, respectively. E. coli grow in 79% of the urine culture positive patients. In a comparison of 3 age groups (<40 years, 40-60 years, >61 years), the elderly patients had a greater number of underlying diseases and more pathogens in cultured blood. When divided into males and females, the elderly male patients had more pathogen in cultured urine, but contrary to the male patients, the elderly female patients had elevated leukocyte count and erythrocyte sedimentation rate. Also, the old patient group had more resistance to ampicillin when they had E. coli as the uropathogen (p=0.021). Patients with higher ESR required longer hospital admission periods. CONCLUSIONS: It was found that variable clinical parameters of acute pyelonephritis patients treated with inpatient therapy differed according to both gender and age group in Korea. Therefore, these factors should be taken into account in the treatment plan.
Aged
;
Ampicillin
;
Blood Sedimentation
;
C-Reactive Protein
;
Female
;
Humans
;
Inpatients
;
Korea
;
Leukocyte Count
;
Male
;
Medical Records
;
Pyelonephritis*
;
Pyuria
;
Retrospective Studies
10.Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma
Jae Seung LEE ; Young Eun CHON ; Beom Kyung KIM ; Jun Yong PARK ; Do Young KIM ; Sang Hoon AHN ; Kwang-Hyub HAN ; Wonseok KANG ; Moon Seok CHOI ; Geum-Youn GWAK ; Yong-Han PAIK ; Joon Hyeok LEE ; Kwang Cheol KOH ; Seung Woon PAIK ; Hwi Young KIM ; Tae Hun KIM ; Kwon YOO ; Yeonjung HA ; Mi Na KIM ; Joo Ho LEE ; Seong Gyu HWANG ; Soon Sun KIM ; Hyo Jung CHO ; Jae Youn CHEONG ; Sung Won CHO ; Seung Ha PARK ; Nae-Yun HEO ; Young Mi HONG ; Ki Tae YOON ; Mong CHO ; Jung Gil PARK ; Min Kyu KANG ; Soo Young PARK ; Young Oh KWEON ; Won Young TAK ; Se Young JANG ; Dong Hyun SINN ; Seung Up KIM ;
Yonsei Medical Journal 2021;62(1):12-20
Purpose:
Alpha-fetoprotein (AFP) is a prognostic marker for hepatocellular carcinoma (HCC). We investigated the prognostic value of AFP levels in patients who achieved complete response (CR) to transarterial chemoembolization (TACE) for HCC.
Materials and Methods:
Between 2005 and 2018, 890 patients with HCC who achieved a CR to TACE were recruited. An AFP responder was defined as a patient who showed elevated levels of AFP (>10 ng/mL) during TACE, but showed normalization or a >50% reduction in AFP levels after achieving a CR.
Results:
Among the recruited patients, 569 (63.9%) with naïve HCC and 321 (36.1%) with recurrent HCC after complete resection were treated. Before TACE, 305 (34.3%) patients had multiple tumors, 219 (24.6%) had a maximal tumor size >3 cm, and 22 (2.5%) had portal vein tumor thrombosis. The median AFP level after achieving a CR was 6.36 ng/mL. After a CR, 473 (53.1%) patients experienced recurrence, and 417 (46.9%) died [median progression-free survival (PFS) and overall survival (OS) of 16.3 and 62.8 months, respectively]. High AFP levels at CR (>20 ng/mL) were independently associated with a shorter PFS [hazard ratio (HR)=1.403] and OS (HR=1.284), together with tumor multiplicity at TACE (HR=1.518 and 1.666, respectively). AFP non-responders at CR (76.2%, n=359 of 471) showed a shorter PFS (median 10.5 months vs. 15.5 months, HR=1.375) and OS (median 41.4 months vs. 61.8 months, HR=1.424) than AFP responders (all p=0.001).
Conclusion
High AFP levels and AFP non-responders were independently associated with poor outcomes after TACE. AFP holds clinical implications for detailed risk stratification upon achieving a CR after TACE.